Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kantoci

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Life Sciences|February 19, 2000
Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofenW J Wechter, E D Murray, D Kantoci, et al.
Cancer Research|October 23, 1997
R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancerW J Wechter, D Kantoci, E D Murray, et al.
Journal of Clinical Pharmacology|June 1, 1996
Antiproliferative effects of the enantiomers of flurbiprofenJ D McCracken, W J Wechter, Y Liu, et al.
Digestive Diseases and Sciences|July 4, 1998
Mechanism of enhancement of intestinal ulcerogenicity of S-aryl propionic acids by their R-enantiomers in the ratW J Wechter, J D McCracken, D Kantoci, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptidesS Horvat, L Varga-Defterdarović, J Horvat, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alphaE D Murray, W J Wechter, D Kantoci, et al.
Life Sciences|January 1, 1995
Endogenous natriuretic factors 3: isolation and characterization of human natriuretic factors LLU-alpha, LLU-beta 1, and LLU-gammaE D Murray, D Kantoci, S A DeWind, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Life Sciences|February 19, 2000
Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofenW J Wechter, E D Murray, D Kantoci, et al.
Cancer Research|October 23, 1997
R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancerW J Wechter, D Kantoci, E D Murray, et al.
Journal of Clinical Pharmacology|June 1, 1996
Antiproliferative effects of the enantiomers of flurbiprofenJ D McCracken, W J Wechter, Y Liu, et al.
Digestive Diseases and Sciences|July 4, 1998
Mechanism of enhancement of intestinal ulcerogenicity of S-aryl propionic acids by their R-enantiomers in the ratW J Wechter, J D McCracken, D Kantoci, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptidesS Horvat, L Varga-Defterdarović, J Horvat, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alphaE D Murray, W J Wechter, D Kantoci, et al.
Life Sciences|January 1, 1995
Endogenous natriuretic factors 3: isolation and characterization of human natriuretic factors LLU-alpha, LLU-beta 1, and LLU-gammaE D Murray, D Kantoci, S A DeWind, et al.
Pageof 2